These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23334342)

  • 1. Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.
    Adlhoch C; Hoehne M; Littmann M; Marques AM; Lerche A; Dehnert M; Eckmanns T; Wichmann O; Koch J
    Pediatr Infect Dis J; 2013 Feb; 32(2):e82-9. PubMed ID: 23334342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
    Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
    Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly.
    Markkula J; Hemming-Harlo M; Salminen MT; Savolainen-Kopra C; Pirhonen J; Al-Hello H; Vesikari T
    Infect Dis (Lond); 2017 May; 49(5):388-395. PubMed ID: 28067093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Rotavirus Genotypes in Korea 5 Years after the Introduction of Rotavirus Vaccines.
    Chung JY; Kim MS; Jung TW; Kim SJ; Kang JH; Han SB; Kim SY; Rhim JW; Kim HM; Park JH; Jo DS; Ma SH; Jeong HS; Cheon DS; Kim JH
    J Korean Med Sci; 2015 Oct; 30(10):1471-5. PubMed ID: 26425045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach.
    Weidemann F; Dehnert M; Koch J; Wichmann O; Höhle M
    Vaccine; 2014 Sep; 32(40):5250-7. PubMed ID: 25045820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus vaccination in Germany: analysis of nationwide surveillance data 2006 to 2010.
    Uhlig U; Kostev K; Schuster V; Uhlig HH
    Pediatr Infect Dis J; 2011 Dec; 30(12):e244-7. PubMed ID: 21817956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses.
    Matthijnssens J; Zeller M; Heylen E; De Coster S; Vercauteren J; Braeckman T; Van Herck K; Meyer N; Pirçon JY; Soriano-Gabarro M; Azou M; Capiau H; De Koster J; Maernoudt AS; Raes M; Verdonck L; Verghote M; Vergison A; Van Damme P; Van Ranst M;
    Clin Microbiol Infect; 2014 Oct; 20(10):O702-10. PubMed ID: 24580887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
    Räsänen S; Lappalainen S; Halkosalo A; Salminen M; Vesikari T
    Scand J Infect Dis; 2011 Jan; 43(1):58-63. PubMed ID: 20807022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of rotavirus vaccination on an emerging G8P[8] rotavirus strain causing an outbreak in central Japan.
    Hoque SA; Kobayashi M; Takanashi S; Anwar KS; Watanabe T; Khamrin P; Okitsu S; Hayakawa S; Ushijima H
    Vaccine; 2018 Jan; 36(1):43-49. PubMed ID: 29183732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal Mass Vaccination Against Rotavirus: Indirect Effects on Rotavirus Infections in Neonates and Unvaccinated Young Infants Not Eligible for Vaccination.
    Prelog M; Gorth P; Zwazl I; Kleines M; Streng A; Zlamy M; Heinz-Erian P; Wiedermann U
    J Infect Dis; 2016 Aug; 214(4):546-55. PubMed ID: 27190178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G2P[4] the most prevalent rotavirus genotype in 2007 winter season in an European non-vaccinated population.
    Antunes H; Afonso A; Iturriza M; Martinho I; Ribeiro C; Rocha S; Magalhães C; Carvalho L; Branca F; Gray J
    J Clin Virol; 2009 May; 45(1):76-8. PubMed ID: 19375980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.
    Correia JB; Patel MM; Nakagomi O; Montenegro FM; Germano EM; Correia NB; Cuevas LE; Parashar UD; Cunliffe NA; Nakagomi T
    J Infect Dis; 2010 Feb; 201(3):363-9. PubMed ID: 20047501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of rotavirus vaccination in Germany: rotavirus surveillance, hospitalization, side effects and comparison of vaccines.
    Uhlig U; Kostev K; Schuster V; Koletzko S; Uhlig HH
    Pediatr Infect Dis J; 2014 Nov; 33(11):e299-304. PubMed ID: 24911897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.
    Gastañaduy PA; Steenhoff AP; Mokomane M; Esona MD; Bowen MD; Jibril H; Pernica JM; Mazhani L; Smieja M; Tate JE; Parashar UD; Goldfarb DM
    Clin Infect Dis; 2016 May; 62 Suppl 2():S161-7. PubMed ID: 27059351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus genotype trends from 2013 to 2018 and vaccine effectiveness in southern Vietnam.
    Truong DTT; Kang JM; Tran NTH; Phan LT; Nguyen HT; Ho TV; Nguyen TTT; Hoang PL; Pham TMT; Nguyen TD; Hoang TA; Luong QC; Pham QD; Ahn JG; Yoon S; Nguyen TV; Yeom JS
    Int J Infect Dis; 2021 Apr; 105():277-285. PubMed ID: 33596479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study.
    Ichihara MY; Rodrigues LC; Teles Santos CA; Teixeira Mda G; De Jesus SR; Alvim De Matos SM; Gagliardi Leite JP; Barreto ML
    Vaccine; 2014 May; 32(23):2740-7. PubMed ID: 24508336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background paper to the recommendation for routine rotavirus vaccination of infants in Germany.
    Koch J; Wiese-Posselt M; Remschmidt C; Wichmann O; Bertelsmann H; Garbe E; Hengel H; Meerpohl JJ; Mas Marques A; Oppermann H; Hummers-Pradier E; von Kries R; Mertens T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Jul; 56(7):957-84. PubMed ID: 23807405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia.
    Beres LK; Tate JE; Njobvu L; Chibwe B; Rudd C; Guffey MB; Stringer JS; Parashar UD; Chilengi R
    Clin Infect Dis; 2016 May; 62 Suppl 2():S175-82. PubMed ID: 27059353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.